EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants

Alejandro Carazo iD, Markéta Paclíková, Jaka Fadraersada, Raúl Alva-Gallegos, Pavel Skořepa, Catherine Gunaseelan, Kateřina Matoušová, Kristýna Mrštná, Lenka Kujovská Krčmová iD, Alena Šmahelová, Vladimír Blaha, Přemysl Mladěnka iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0326580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Alejandro Carazo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic. Hauptthemen laut MEDLINE: Anticoagulants, Vitamin K, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agentura Pro Zdravotnický Výzkum České Republiky, European Union, Univerzita Karlova v Praze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The abnormalities in blood coagulation in patients with diabetes can lead to a prothrombotic state and requirement for the administration of direct anticoagulants. However, no comparative studies have been conducted on the effects of different direct anticoagulants. A head-to-head investigation of the impact of anticoagulants in 50 patients of type 1 diabetes mellitus (DMT1) was performed, and the data were compared to 50 generally healthy individuals. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) were measured in plasma treated with vehicle, heparin, or four direct anticoagulants at 1 μM. In addition to common biochemical parameters, novel inflammatory markers (neopterin, kynurenine/tryptophan ratio) and major vitamin K forms were measured. Heparin and dabigatran treatments resulted in prolonged coagulation in DMT1 patients compared to healthy individuals in both tests (both p < 0.001). The same phenomenon was observed for rivaroxaban and apixaban-treated samples in PT (p < 0.001). Interestingly, healthy volunteers had higher total vitamin K levels than DMT1. Further analysis suggested that observed coagulation differences were not caused by differences in glycemia but were rather associated with an unexpected, better lipid profile of our DMT1 group. There were also correlations between prolongation of coagulation brought about by the most active anticoagulants and inflammatory markers, and hence inflammatory state probably also contributed to the differences, as well as the mentioned differences in vitamin K levels. Conclusively, this paper suggests the suitability for controlling the effects of direct anticoagulants in DMT1 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticoagulantsVitamin KDiabetes Mellitus, Type 1HumansMaleFemaleAdultBlood CoagulationProthrombin TimeMiddle AgedPartial Thromboplastin TimeHeparinYoung AdultRivaroxabanDabigatranCase-Control Studies

Substanzen

AnticoagulantsVitamin KHeparinRivaroxabanDabigatran

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • 3rd Department of Internal Medicine-Metabolic Care and Gerontology, University Hospital and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Department of Military Internal Medicine and Military Hygiene, Military Faculty of Medicine, University of Defence, Hradec Králové, Czech Republic.
  • Department of Clinical Biochemistry and Diagnostics, University Hospital, Hradec Králové, Czech Republic.
  • Department of Analytical Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.

ORCID-Profile: Alejandro Carazo, Lenka Kujovská Krčmová, Přemysl Mladěnka

Förderung

  • Agentura Pro Zdravotnický Výzkum České Republiky
  • European Union
  • Univerzita Karlova v Praze
  • MH CZ - DRO

Zitieren

APA

Carazo, A., Paclíková, M., Fadraersada, J., Alva-Gallegos, R., Skořepa, P., Gunaseelan, C., Matoušová, K., Mrštná, K., Krčmová, L. K., Šmahelová, A., Blaha, V., & Mladěnka, P. (2025). Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants. PLOS One. https://doi.org/10.1371/journal.pone.0326580

Vancouver

Carazo A, Paclíková M, Fadraersada J, Alva-Gallegos R, Skořepa P, Gunaseelan C, et al. Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants. PLOS One. 2025. doi:10.1371/journal.pone.0326580

BibTeX
@article{Carazo2025,
  author = {Carazo, Alejandro and Paclíková, Markéta and Fadraersada, Jaka and Alva-Gallegos, Raúl and Skořepa, Pavel and Gunaseelan, Catherine and Matoušová, Kateřina and Mrštná, Kristýna and Krčmová, Lenka Kujovská and Šmahelová, Alena and Blaha, Vladimír and Mladěnka, Přemysl},
  title = {Type 1 diabetes mellitus patients had lower total vitamin K levels and increased sensitivity to direct anticoagulants},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0326580}
}
Kostenlos starten →